<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39435611</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of medicine</Title><ISOAbbreviation>Ann Med</ISOAbbreviation></Journal><ArticleTitle>Reevaluation of prognostic and severity indicators for COVID-19 patients in the emergency department.</ArticleTitle><Pagination><StartPage>2417178</StartPage><MedlinePgn>2417178</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2417178</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2024.2417178</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="UNASSIGNED">This study aimed to re-evaluate whether the scoring systems, neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were effective in predicting prognosis and severity of COVID-19 patients in the emergency department (ED).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">COVID-19 patients enrolled in this retrospective study divided into the death (DEA) and survival (SUR) groups, the severe/critical (SC) and non-severe/critical (non-SC) groups. The Acute Physiology and Chronic Health Evaluation (APACHE) II, Sequential Organ Failure Assessment (SOFA), National Early Warning Score (NEWS) and CCEDRRN COVID-19 Mortality Score were calculated. The neutrophil, lymphocyte and platelet counts were extracted from the first routine blood examination, and NLR and PLR were calculated accordingly. Receiver Operating Characteristic (ROC) curve and logistic regression were performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">All the scoring systems, as well as NLR and PLR, significantly increased in both the DEA and SC groups. The ROC curve showed that the CCEDRRN COVID-19 Mortality Score had the highest predictive value for mortality and severity (AUC 0.779, 0.850, respectively), which outperformed the APACHE II, SOFA and NEWS. NLR presented better predictive ability for severity (AUC 0.741) than death (AUC 0.702). The APACHE II, NEWS and CCEDRRN COVID-19 Mortality Score were positively correlated with both prognosis and severity, whereas NLR only with severity.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The NEWS and CCEDRRN COVID-19 Mortality Score were reconfirmed for early and rapid predicting the poor prognosis and severity of COVID-19 patients in ED, especially the CCEDRRN COVID-19 Mortality Score with the highest discrimination capacity, and NLR was more appropriate for predicting the severity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yi-Jie</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Emergency, Emergency and Critical Care Medical Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiao-Yan</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Infection, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Wan-Xin</ForeName><Initials>WX</Initials><AffiliationInfo><Affiliation>Department of Emergency, Emergency and Critical Care Medical Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ya-Peng</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med</MedlineTA><NlmUniqueID>8906388</NlmUniqueID><ISSNLinking>0785-3890</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="Y">Emergency Service, Hospital</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="Y">Neutrophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018655" MajorTopicYN="N">Lymphocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010976" MajorTopicYN="N">Platelet Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018806" MajorTopicYN="N">APACHE</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="N">Organ Dysfunction Scores</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APACHE II</Keyword><Keyword MajorTopicYN="N">CCEDRRN COVID-19 mortality score</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">NEWS</Keyword><Keyword MajorTopicYN="N">NLR</Keyword><Keyword MajorTopicYN="N">PLR</Keyword><Keyword MajorTopicYN="N">SOFA</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword><Keyword MajorTopicYN="N">severity</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39435611</ArticleId><ArticleId IdType="pmc">PMC11497573</ArticleId><ArticleId IdType="doi">10.1080/07853890.2024.2417178</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen J, Wang R, Gilby NB, et al. . Omicron variant (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance. J Chem Inf Model. 2022;62(2):412–422. doi: 10.1021/acs.jcim.1c01451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.1c01451</ArticleId><ArticleId IdType="pmc">PMC8751645</ArticleId><ArticleId IdType="pubmed">34989238</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo Marin B, Aghagoli G, Lavine K, et al. . Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021;31(1):1–10. doi: 10.1002/rmv.2146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2146</ArticleId><ArticleId IdType="pmc">PMC7855377</ArticleId><ArticleId IdType="pubmed">32845042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponti G, Maccaferri M, Ruini C, et al. . Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57(6):389–399. doi: 10.1080/10408363.2020.1770685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1770685</ArticleId><ArticleId IdType="pmc">PMC7284147</ArticleId><ArticleId IdType="pubmed">32503382</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar PG, Pant P, Kumar J, et al. . Does neutrophil-to-lymphocyte ratio at admission predict severity and mortality in COVID-19 patients? A systematic review and meta-analysis. Indian J Crit Care Med. 2022;26(3):361–375. doi: 10.5005/jp-journals-10071-24135.</Citation><ArticleIdList><ArticleId IdType="doi">10.5005/jp-journals-10071-24135</ArticleId><ArticleId IdType="pmc">PMC9015924</ArticleId><ArticleId IdType="pubmed">35519918</ArticleId></ArticleIdList></Reference><Reference><Citation>Khadzhieva MB, Gracheva AS, Belopolskaya OB, et al. . Serial changes in blood-cell-count-derived and CRP-derived inflammatory indices of COVID-19 patients. Diagnostics (Basel). 2023;13(4):746. doi: 10.3390/diagnostics13040746.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13040746</ArticleId><ArticleId IdType="pmc">PMC9955197</ArticleId><ArticleId IdType="pubmed">36832234</ArticleId></ArticleIdList></Reference><Reference><Citation>Asperges E, Albi G, Zuccaro V, et al. . Dynamic NLR and PLR in predicting COVID-19 severity: a retrospective ­cohort study. Infect Dis Ther. 2023;12(6):1625–1640. doi: 10.1007/s40121-023-00813-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-023-00813-1</ArticleId><ArticleId IdType="pmc">PMC10191087</ArticleId><ArticleId IdType="pubmed">37198387</ArticleId></ArticleIdList></Reference><Reference><Citation>Dymicka-Piekarska V, Dorf J, Milewska A, et al. . Neutrophil/lymphocyte ratio (NLR) and lymphocyte/monocyte ratio (LMR)—risk of death inflammatory biomarkers in patients with COVID-19. J Inflamm Res. 2023;16:2209–2222. doi: 10.2147/JIR.S409871.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S409871</ArticleId><ArticleId IdType="pmc">PMC10224725</ArticleId><ArticleId IdType="pubmed">37250103</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger JS, Kunichoff D, Adhikari S, et al. . Prevalence and outcomes of D-dimer elevation in hospitalized patients with COVID-19. Arterioscler Thromb Vasc Biol. 2020;40(10):2539–2547. doi: 10.1161/atvbaha.120.314872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/atvbaha.120.314872</ArticleId><ArticleId IdType="pmc">PMC7505147</ArticleId><ArticleId IdType="pubmed">32840379</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas-Rojo JM, Antón-Santos JM, Millán-Núñez-Cortés J, et al. . Características clínicas de los pacientes hospitalizados con COVID-19 en España: resultados del Registro SEMI-COVID-19 [Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 registry]. Rev Clin Esp. 2020;220(8):480–494. doi: 10.1016/j.rce.2020.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rce.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7368900</ArticleId><ArticleId IdType="pubmed">33994573</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruangsomboon O, Phanprasert N, Jirathanavichai S, et al. . The utility of the rapid emergency medicine score (REMS) compared with three other early warning scores in predicting in-hospital mortality among COVID-19 ­patients in the emergency department: a multicenter validation study. BMC Emerg Med. 2023;23(1):45. doi: 10.1186/s12873-023-00814-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12873-023-00814-w</ArticleId><ArticleId IdType="pmc">PMC10132401</ArticleId><ArticleId IdType="pubmed">37101141</ArticleId></ArticleIdList></Reference><Reference><Citation>Martín-Rodríguez F, Martín-Conty JL, Sanz-García A, et al. . Early warning scores in patients with suspected COVID-19 infection in emergency departments. J Pers Med. 2021;11(3):170. doi: 10.3390/jpm11030170.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11030170</ArticleId><ArticleId IdType="pmc">PMC8001393</ArticleId><ArticleId IdType="pubmed">33801375</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H, Yao N, Qiu Y.. Predictive value of 5 early warning scores for critical COVID-19 patients. Disaster Med Public Health Prep. 2022;16(1):232–239. doi: 10.1017/dmp.2020.324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/dmp.2020.324</ArticleId><ArticleId IdType="pmc">PMC7596567</ArticleId><ArticleId IdType="pubmed">32900406</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott LJ, Tavaré A, Hill EM, et al. . Prognostic value of National Early Warning Scores (NEWS2) and component physiology in hospitalised patients with COVID-19: a multicentre study. Emerg Med J. 2022;39(8):589–594. doi: 10.1136/emermed-2020-210624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2020-210624</ArticleId><ArticleId IdType="pmc">PMC8931800</ArticleId><ArticleId IdType="pubmed">35292484</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr E, Bendayan R, Bean D, et al. . Evaluation and ­improvement of the National Early Warning Score (NEWS2) for COVID-19: a multi-hospital study. BMC Med. 2021;19(1):23. doi: 10.1186/s12916-020-01893-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01893-3</ArticleId><ArticleId IdType="pmc">PMC7817348</ArticleId><ArticleId IdType="pubmed">33472631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostakis I, Smith GB, Prytherch D, et al. . The performance of the National Early Warning Score and National Early Warning Score 2 in hospitalised patients infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Resuscitation. 2021;159:150–157. doi: 10.1016/j.resuscitation.2020.10.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2020.10.039</ArticleId><ArticleId IdType="pmc">PMC7648887</ArticleId><ArticleId IdType="pubmed">33176170</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker KF, Hanrath AT, Schim van der Loeff I, et al. . National Early Warning Score 2 (NEWS2) to identify ­inpatient COVID-19 deterioration: a retrospective ­analysis. Clin Med (Lond). 2021;21(2):84–89. doi: 10.7861/clinmed.2020-0688.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0688</ArticleId><ArticleId IdType="pmc">PMC8002770</ArticleId><ArticleId IdType="pubmed">33547065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohl CM, Rosychuk RJ, Archambault PM, et al. . The CCEDRRN COVID-19 Mortality Score to predict death among nonpalliative patients with COVID-19 presenting to emergency departments: a derivation and validation study. cmajo. 2022;10(1):E90–e99. doi: 10.9778/cmajo.20210243.</Citation><ArticleIdList><ArticleId IdType="doi">10.9778/cmajo.20210243</ArticleId><ArticleId IdType="pmc">PMC9259439</ArticleId><ArticleId IdType="pubmed">35135824</ArticleId></ArticleIdList></Reference><Reference><Citation>Swiss Society, Of Intensive, Care M. Recommendations for the admission of patients with COVID-19 to intensive care and intermediate care units (ICUs and IMCUs). Swiss Med Wkly. 2020;150:w20227. doi: 10.4414/smw.2020.20227.</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smw.2020.20227</ArticleId><ArticleId IdType="pubmed">32208493</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health (US); 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Royal College of Physicians. National Early Warning Score (NEWS): Standardising the assessment of acute-illness severity in the NHS. RCP, 2012.</Citation></Reference><Reference><Citation>Nahm FS. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol. 2022;75(1):25–36. doi: 10.4097/kja.21209.</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kja.21209</ArticleId><ArticleId IdType="pmc">PMC8831439</ArticleId><ArticleId IdType="pubmed">35124947</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw AC, Joshi S, Greenwood H, et al. . Aging of the ­innate immune system. Curr Opin Immunol. 2010;22(4):507–513. doi: 10.1016/j.coi.2010.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2010.05.003</ArticleId><ArticleId IdType="pmc">PMC4034446</ArticleId><ArticleId IdType="pubmed">20667703</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JJ, Dong X, Liu GH, et al. . Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin Rev Allergy Immunol. 2023;64(1):90–107. doi: 10.1007/s12016-022-08921-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-022-08921-5</ArticleId><ArticleId IdType="pmc">PMC8767775</ArticleId><ArticleId IdType="pubmed">35044620</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao YD, Ding M, Dong X, et al. . Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76(2):428–455. doi: 10.1111/all.14657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14657</ArticleId><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijls BG, Jolani S, Atherley A, et al. . Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ Open. 2021;11(1):e044640. doi: 10.1136/bmjopen-2020-044640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-044640</ArticleId><ArticleId IdType="pmc">PMC7802392</ArticleId><ArticleId IdType="pubmed">33431495</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Ni ZY, Hu Y, et al. . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisco G, De Tullio A, Stragapede A, et al. . COVID-19 and the endocrine system: a comprehensive review on the theme. J Clin Med. 2021;10(13):2920. doi: 10.3390/jcm10132920.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132920</ArticleId><ArticleId IdType="pmc">PMC8269331</ArticleId><ArticleId IdType="pubmed">34209964</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos V, Li L, Samplaski M.. Why does COVID-19 kill more elderly men than women? Is there a role for testosterone? Andrology. 2021;9(1):65–72. doi: 10.1111/andr.12868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.12868</ArticleId><ArticleId IdType="pmc">PMC7404939</ArticleId><ArticleId IdType="pubmed">32681716</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes S, Sérvio R, Patrício P, et al. . Validation of the acute physiology and chronic health evaluation (APACHE) II score in COVID-19 patients admitted to the intensive care unit in times of resource scarcity. Cureus. 2023;15(2):e34721. doi: 10.7759/cureus.34721.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.34721</ArticleId><ArticleId IdType="pmc">PMC9998113</ArticleId><ArticleId IdType="pubmed">36909097</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou X, Li S, Fang M, et al. . Acute physiology and chronic health evaluation II score as a predictor of hospital mortality in patients of coronavirus disease 2019. Crit Care Med. 2020;48(8):e657–e665. doi: 10.1097/ccm.0000000000004411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ccm.0000000000004411</ArticleId><ArticleId IdType="pmc">PMC7217128</ArticleId><ArticleId IdType="pubmed">32697506</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicka V, Januskeviciute E, Miskinyte S, et al. . Comparison of mortality risk evaluation tools efficacy in critically ill COVID-19 patients. BMC Infect Dis. 2021;21(1):1173. doi: 10.1186/s12879-021-06866-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06866-2</ArticleId><ArticleId IdType="pmc">PMC8607225</ArticleId><ArticleId IdType="pubmed">34809594</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigmohammadi MT, Amoozadeh L, Rezaei Motlagh F, et al. . Mortality predictive value of APACHE II and SOFA scores in COVID-19 patients in the intensive care unit. Can Respir J. 2022;2022:5129314–5129318. doi: 10.1155/2022/5129314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/5129314</ArticleId><ArticleId IdType="pmc">PMC8958381</ArticleId><ArticleId IdType="pubmed">35356088</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente L, Martín MM, González-Rivero AF, et al. . DNA and RNA oxidative damage and mortality of patients with COVID-19. Am J Med Sci. 2021;361(5):585–590. doi: 10.1016/j.amjms.2021.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2021.02.012</ArticleId><ArticleId IdType="pmc">PMC7884223</ArticleId><ArticleId IdType="pubmed">33600784</ArticleId></ArticleIdList></Reference><Reference><Citation>Marincowitz C, Hasan M, Omer Y, et al. . Prognostic accuracy of eight triage scores in suspected COVID-19 in an emergency department low-income setting: an observational cohort study. Afr J Emerg Med. 2024;14(1):51–57. doi: 10.1016/j.afjem.2023.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.afjem.2023.12.004</ArticleId><ArticleId IdType="pmc">PMC10839866</ArticleId><ArticleId IdType="pubmed">38317781</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop RJ, Rodriguez-Feuerhahn M, Schedlowski M.. Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav Immun. 1996;10(2):77–91. doi: 10.1006/brbi.1996.0009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/brbi.1996.0009</ArticleId><ArticleId IdType="pubmed">8811932</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>